Ping An Biomedical Co., Ltd.
PASWConsumer CyclicalNASDAQTextile Manufacturing · Last scanned Oct 22, 2026
Scan Results
Daily timeframePing An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The $11.5M market capitalization puts PASW squarely in micro-cap range for its industry. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.
Market Cap
$11.5M
Beta
—
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-0.06
EPS (Fwd)
—
ROE
-11.3%
ROA
-8.9%
Cash
$6.8M
Total Debt
$10.3M
Free CF
-$46.4M
52W Change
-87.3%
Annual Financials
Cash vs Debt
Where PASW stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, PASW finished 13.33% below its 150-day moving average ($0.15) and 23.53% below its 200-day moving average ($0.17). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PASW overbought or oversold?
At the October 20, 2026 close, PASW's RSI(14) was 55.7, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Ping An Biomedical Co., Ltd. carries $10.3M in total debt against $6.8M in cash reserves — debt is roughly 1.5x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company is burning cash, with free cash flow at -$46.4M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -11.3%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $114.5M (2022) to $34.1M (2025), a 70% decline worth watching.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing PASW's risk profile alongside its fundamentals and technical indicators provides a more complete picture.